XML 67 R49.htm IDEA: XBRL DOCUMENT v3.24.0.1
Acquisitions - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Oct. 17, 2023
Dec. 31, 2023
Dec. 31, 2021
Dec. 30, 2021
Dec. 08, 2021
Sep. 30, 2021
Feb. 25, 2021
Jan. 15, 2021
Business Acquisition [Line Items]                
Weighted-average amortization period   17 years 14 years          
European Viral Vector Business                
Business Acquisition [Line Items]                
Goodwill recorded               $ 0
Mesa Biotech                
Business Acquisition [Line Items]                
Goodwill recorded             $ 0  
Lengnau biologics manufacturing facility                
Business Acquisition [Line Items]                
Goodwill recorded           $ 0    
PPD                
Business Acquisition [Line Items]                
Goodwill recorded         $ 0      
Net income attributable to Thermo Fisher Scientific Inc.     $ 7,369          
Pro forma revenues     378          
Pro forma losses     (60)          
PPD | Non-recurring Pro Forma Adjustments, Transaction Costs                
Business Acquisition [Line Items]                
Net income attributable to Thermo Fisher Scientific Inc.     $ 312          
PeproTech                
Business Acquisition [Line Items]                
Goodwill recorded       $ 0        
Olink Holding AB                
Business Acquisition [Line Items]                
Expected price per share (dollars per share) $ 26.00              
Expected acquisition price $ 3,100              
Customer relationships                
Business Acquisition [Line Items]                
Weighted-average amortization period   18 years 17 years          
Product technology                
Business Acquisition [Line Items]                
Weighted-average amortization period   14 years 11 years          
Tradenames                
Business Acquisition [Line Items]                
Weighted-average amortization period   15 years 7 years          
Backlog                
Business Acquisition [Line Items]                
Weighted-average amortization period   13 years 3 years